| Literature DB >> 25006333 |
Feng Chen1, Yanwei Wang1, Jun Ma1, Guangcan Yang1.
Abstract
Gold nanoparticles' novel properties are widely realized in catalysis, plasmonics, electronics, and biomedical applications. For biomedical application, one challenge is to find a non-toxic chemical and/or physical method of functionalizing gold nanoparticles with biomolecular compounds that can promote efficient binding, clearance, and biocompatibility and to assess their safety to other biological systems and their long-term effects on human health and reproduction. In the present study, we describe a new method by using Tris(hydroxymethyl)aminomethane (Tris), a widely used buffer solvent of nucleic acid and proteins, as the reducing agent for synthesizing gold nanoparticles by one step. It is found that Tris carries out the reduction reactions in relatively mild conditions for biomacromolecules. Particularly, it can be used to modify the DNA during the process of preparation of gold nanoparticles. The morphology and size distribution of gold nanoparticles are consistent and were confirmed by many different approaches including dynamic light scattering (DLS), UV-visible (UV-vis) spectrophotometry, atomic force microscopy (AFM), and transmission electron microscopy (TEM).Entities:
Keywords: Biocompatible; Gold nanoparticle; Tris(hydroxymethyl)aminomethane
Year: 2014 PMID: 25006333 PMCID: PMC4078098 DOI: 10.1186/1556-276X-9-220
Source DB: PubMed Journal: Nanoscale Res Lett ISSN: 1556-276X Impact factor: 4.703
Figure 1UV-vis spectra for AuNPs synthesized by Tris. The black line corresponds to the fresh AuNP UV-vis extinction curve, and the red line is the spectra of the same sample stored for a month.
Figure 2AFM image of AuNPs synthesized by Tris. (A) Fresh sample dropwise added on the mica, and (B) the same sample stored for 2 days, in which the nanoparticles were assembled.
Figure 3TEM images of gold nanoparticles. Gold nanoparticles synthesized by Tris. The insets show higher magnification images and size distribution histogram. The gold nanoparticles have perfect polyhedral structures and nanoparticle diameter = 55.2 ± 8.0 nm.
Figure 4TEM and UV-vis images. (A) Gold nanoparticles by Tris. (B) Nanoparticles by glucose form a variety of structures. (C) Gold nanoparticles by sodium citrate are spherical monodispersed. (D) The UV-vis spectra: the absorbance intensity of AuNPs by citrate methods, glucose method, and Tris method are peaked at 519, 547, and 524 nm, respectively.
Dynamic light scattering (DLS) data of the size distributions of three kinds of gold nanoparticles
| Citrate | 13.15 | 12.60 | 13.05 | 12.58 | 13.10 | 12.90 | |
| 100 | 100 | 98.8 | 97.8 | 98.6 | |||
| Glucose | 23.95 | 23.91 | 23.64 | 23.53 | 23.94 | 23.79 | |
| 87.2 | 86.0 | 86.6 | 87.6 | 88.3 | |||
| Tris | 57.63 | 62.42 | 57.37 | 57.63 | 61.40 | 59.29 | |
| 92.2 | 96.2 | 95.9 | 95.7 | 93.4 | |||
I represents the percentage of the main AuNPs in total particles.
Zeta potential and mobility of pure DNA and gold nanoparticles prepared using Tris-DNA mixture at 25°C
| Pure DNA | −36.5 | −2.858 |
| Au-DNA | −36.0 | −2.824 |
Figure 5The UV-vis spectrum of Au-DNA and DNA solution.